Tizanidine- Medical Intermediates

Looking for high-quality Tizanidine medical intermediates? Look no further! We are a trusted factory providing top-notch products. Contact us today!

Request a Quote
  • Tizanidine- Medical Intermediates

PRODUCTS DETAILS

Basic Information
Product name Tizanidine
Grade Pharma grade
Appearance White Powder
Assay 99%
Shelf life 2 years
Packing 25kg/drum
Condition Store at -20°C
Tizanidine is an imidazoline two nitrogen heterocyclic pentene derivative. The structure is similar to that of clonidine. In 1987, it was first listed in Finland as a central adrenalin α2 receptor agonist. Currently, it is used as a central muscle relaxant in clinic. It can be used to treat painful muscle spasm, such as neck waist syndrome and torticollis. It can also be used to treat postoperative pain, such as disc herniation and hip arthritis. It comes from the ankylosis of neurological disorders, such as multiple sclerosis, chronic myelopathy, cerebrovascular accident and etc.It is used to reduce skeletal muscle tension, muscle spasm and myotonia caused by brain and spinal cord injury, cerebral hemorrhage, encephalitis and multiple sclerosis.Labeled Tizanidine, intended for use as an internal standard for the quantification of Tizanidine by GC- or LC-mass spectrometry. Tizanidine could have therapeutic use as a SARS-CoV-2 main protease inhibitor.It selectively reduces the release of excitatory amino acids from interneurons and inhibits the multi synaptic mechanism related to muscle overstrain. This product does not affect the transmission of neuromuscular. It is well tolerated. It is effective for acute painful muscle spasms and chronic ankylosis originates from the spinal cord and brain. It can reduce the resistance of passive movement, reduce spasticity and clonus, and increase the intensity of voluntary movement.Tizanidine is a centrally active muscle relaxant analogue of clonidine that is approved for use in reducing spasticity associated with cerebral or spinal cord injury. Its mechanism of action for reducing spasticity suggests presynaptic inhibition of motor neurons at the α2-adrenergic receptor sites, reducing the release of excitatory amino acids and inhibiting facilitatory ceruleospinal pathways, thus resulting in a reduction in spasticity. Tizanidine only has a small fraction of the antihypertensive action of clonidine, presumably because of action at a selective subgroup of α2C-adrenoceptors, which appear to be responsible for the analgesic and antispasmodic activity of  imidazoline α2-agonists(20).Tizanidine is a centrally acting adrenergic α2 receptor agonist used to treat chronic muscle spasticity conditions, such as multiple sclerosis.

Hot Products

Vitamin D3 Oil

Vitamin D3 Oil

Quercetin (Pharmaceutical Raw Materials)

Quercetin (Pharmaceutical Raw Materials)

Griseofulvin-In Medical Industry

Griseofulvin-In Medical Industry

Creatine Monohydrate of Nutritional Supplement

Creatine Monohydrate of Nutritional Supplement

Riboflavin (Vitamin B2 98%) Powder

Riboflavin (Vitamin B2 98%) Powder

L-Arginine (High Quality Nutritional Supplement ) Powder

L-Arginine (High Quality Nutritional Supplement ) Powder

China Taurine

China Taurine

Multi Mineral Tablet

Multi Mineral Tablet

Potassium Bicarbonate Food Additives

Potassium Bicarbonate Food Additives

Good D-glucosamine Hydrochloride For Food Additives

Good D-glucosamine Hydrochloride For Food Additives

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours